The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin; European Psychiatry; Vol. 65, Special iss. S1 : Abstracts of the 30th European Congress of Psychiatry, June 2022

Detalhes bibliográficos
Parent link:European Psychiatry
Vol. 65, Special iss. S1 : Abstracts of the 30th European Congress of Psychiatry, June 2022.— 2022.— [EPV1515, P. S819 - S820]
Corporate Authors: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий, Национальный исследовательский Томский политехнический университет Школа базовой инженерной подготовки Отделение естественных наук
Outros Autores: Shushpanova T. V. Tamara Vasiljevna, Novozheeva T. P. Tatjana Petrovna, Gutkevich E. V. Elena Vladimirovna, Pustovaya A. S. Aleksandra Sergeevna, Garganeeva N. P. Nataljya Petrovna, Belousov M. Yu. Mikhail Yurjevich, Podjyablonsky A. S. Andrey Sergeevich, Markova E. S. Elena Sergeevna, Knyazeva E. M. Elena Mikhailovna, Shushpanova O. V. Olga Vladimirovna, Kolomiets N. E. Nataljya Eduardovna, Safronov S. N. Sergey Nikolaevich, Boev R. S. Roman Sergeevich
Resumo:Title screen
The anticonvulsant m-Cl-BHM is promising for thepathogenetically directed thrapy does not cause negative effects.
Idioma:inglês
Publicado em: 2022
Assuntos:
Acesso em linha:https://doi.org/10.1192/j.eurpsy.2022.2120
Formato: Recurso Electrónico Capítulo de Livro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=669633
Descrição
Resumo:Title screen
The anticonvulsant m-Cl-BHM is promising for thepathogenetically directed thrapy does not cause negative effects.
DOI:10.1192/j.eurpsy.2022.2120